Successful Health Care Provider Strategies to Overcome Psychological Insulin Resistance in United States and Canada

References

1. 1.↵
   American Diabetes Association. Standards of Medical Care in Diabetes—2018. https://diabetesed.net/wp-content/uploads/2017/12/2018-ADA-Standards-of-Care.pdf. Accessed June 11, 2018.
2. 2.↵
   Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2018;42:S1–S325.

   OpenUrlCrossRefPubMed
3. 3.↵
   Joslin Diabetes Center. Insulin A to Z: a guide on different types of insulin. http://www.joslin.org/info/insulin_a_to_z_a_guide_on_different_types_of_insulin.html. Accessed April 26, 2019.
4. 4.↵
   1. Polonsky WH,
   2. Hajos TR,
   3. Dain MP,
   4. Snoek FJ

   . Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population. Curr Med Res Opin 2011;27:1169–1174.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Oguz A,
   2. Benroubi M,
   3. Brismar K,
   4. et al

   . Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study. Curr Med Res Opin 2013;29:911–920.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Bhattacharya R,
   2. Zhou S,
   3. Wei W,
   4. Ajmera M,
   5. Sambamoorthi U

   . A real-world study of the effect of timing of insulin initiation on outcomes in older medicare beneficiaries with type 2 diabetes mellitus. J Am Geriatr Soc 2015;63:893–901.

   OpenUrl
7. 7.↵
   1. Chen HS,
   2. Wu TE,
   3. Jap TS,
   4. Hsiao LC,
   5. Lee SH,
   6. Lin HD

   . Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy. Diabetes Care 2008;31:1927–32.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Mashitisho MLI,
   2. Mashitisho BG

   . Early insulin therapy in patients with type 2 diabetes mellitus. J Endocrinol Metab Diabetes South Africa 2016;21:13–5.

   OpenUrl
9. 9.↵
   1. Hosomura N,
   2. Malmasi S,
   3. Timerman D,
   4. et al

   . Decline of insulin therapy and delays in insulin initiation in people with uncontrolled diabetes mellitus. Diabet Med 2017;34:1599–1602.

   OpenUrl
10. 10.↵
    1. Polonsky WH,
    2. Fisher L,
    3. Guzman S,
    4. Villa-Caballero L,
    5. Edelman SV

    . Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005;28:2543–2545.

    OpenUrlFREE Full Text
11. 11.↵
    1. Ng CJ,
    2. Lai PS,
    3. Lee YK,
    4. Azmi SA,
    5. Teo CH

    . Barriers and facilitators to starting insulin in patients with type 2 diabetes: a systematic review. Int J Clin Pract 2015;69:1050–1070.

    OpenUrl
12. 12.↵
    1. Nakar S,
    2. Yitzhaki G,
    3. Rosenberg R,
    4. Vinker S

    . Transition to insulin in Type 2 diabetes: family physicians’ misconception of patients’ fears contributes to existing barriers. J Diabetes Complications 2007;21:220–226.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Oliveria SA,
    2. Menditto LA,
    3. Ulcickas Yood M,
    4. Koo YH,
    5. Wells KE,
    6. McCarthy BD

    . Barriers to the initiation of, and persistence with, insulin therapy. Curr Med Res Opin 2007;23:3105–3112.

    OpenUrlPubMed
14. 14.↵
    1. Yavuz DG,
    2. Ozcan S,
    3. Deyneli O

    . Adherence to insulin treatment in insulin-naive type 2 diabetic patients initiated on different insulin regimens. Patient Prefer Adherence 2015;9:1225–1231.

    OpenUrl
15. 15.↵
    1. Larkin ME,
    2. Capasso VA,
    3. Chen CL,
    4. et al

    . Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educ 2008;34:511–517.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Abu Hassan H,
    2. Tohid H,
    3. Mohd Amin R,
    4. Long Bidin MB,
    5. Muthupalaniappen L,
    6. Omar K

    . Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration. BMC Fam Pract 2013;14:164.

    OpenUrl
17. 17.↵
    1. Polonsky WH,
    2. Fisher L,
    3. Hessler D,
    4. et al.

    Identifying solutions to psychological insulin resistance: an international study. J Diabetes Complications 2019;33:307–314.

    OpenUrl
18. 18.↵
    Standards of Medical Care in Diabetes—2018 Abridged for Primary Care Providers. Clin Diabetes 2018;36:14–37.

    OpenUrlFREE Full Text
19. 19.↵
    1. Chew BH,
    2. Shariff-Ghazali S,
    3. Fernandez A

    . Psychological aspects of diabetes care: effecting behavioral change in patients. World J Diabetes 2014;5:796–808.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Heisler A,
    2. Resnicow K

    . Helping patients make and sustain healthy changes: a brief introduction to motivational interviewing in clinical diabetes care. Clin Diabetes 2008;26:161–165.

    OpenUrlFREE Full Text
21. 21.↵
    1. Brunton SA

    . Improving medication adherence in chronic disease management. J Fam Pract 2011;60:S1–S8.

    OpenUrlPubMed
22. 22.↵
    1. Rachmani R,
    2. Slavacheski I,
    3. Berla M,
    4. Frommer-Shapira R,
    5. Ravid M

    . Treatment of high-risk patients with diabetes: motivation and teaching intervention: a randomized, prospective 8-year follow-up study. J Am Soc Nephrol 2005;16:S22–S26.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Brod M,
    2. Alolga SL,
    3. Meneghini L

    . Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities. Patient 2014;7:437–450.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Gauthier B,
    2. Singh SR,
    3. Virani A,
    4. Staples H,
    5. Colbourne A

    . Perspectives and experiences of health care professionals and patients regarding treatments for type 2 diabetes.Can Pharm J (Ott) 2014;147:45–54.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Linetzky B,
    2. Jiang D,
    3. Funnell MM,
    4. Curtis BH,
    5. Polonsky WH

    . Exploring the role of the patient-physician relationship on insulin adherence and clinical outcomes in type 2 diabetes: Insights from the MOSAIc study. J Diabetes 2017;9:596–605.

    OpenUrl
26. 26.↵
    American Diabetes Association. American Diabetes Association and European Association for the Study of Diabetes Issue Joint Position Statement on Hyperglycemia Treatment. 2012; http://www.diabetes.org/newsroom/press-releases/2012/ada-easd-type-2-position-statement.html. Accessed June 20, 2018.
27. 27.↵
    1. Hayes RP,
    2. Fitzgerald JT,
    3. Jacober SJ

    . Primary care physician beliefs about insulin intiation in patients with type 2 diabetes. Int J Clin Pract 2008;62:860–868.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Kalirai S,
    2. Stephenson J,
    3. Perez-Nieves M,
    4. et al

    . Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitus. Prim Care Diabetes 2018;12:155–62.

    OpenUrl
29. 29.↵
    1. Agarwal G,
    2. Nair K,
    3. Cosby J,
    4. et al

    . GPs’ approach to insulin prescribing in older patients: a qualitative study. Br J Gen Pract 2008;58:569–575.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    American Diabetes Association. Statistics About Diabetes. 2018; http://www.diabetes.org/diabetes-basics/statistics/. Accessed July 2, 2018.
31. 31.↵
    Diabetes Canada. Diabetes Statistics in Canada. 2018; http://www.diabetes.ca/how-you-can-help/advocate/why-federal-leadership-is-essential/diabetes-statistics-in-canada. Accessed July 2, 2018.
32. 32.
    1. Snoek FJ,
    2. Skovlund SE,
    3. Pouwer F

    . Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Health Qual Life Outcomes. 2007;5:69.

    OpenUrlCrossRefPubMed